AUM$4.9M
Expense Ratio0.47%
NAV$32.97
Holdings57
InceptionAug 24, 2022
Price Chart
Key Statistics
Previous Close
$32.92Day Range
$32.84$32.86
52-Week Range
$18.44$33.37
Avg Volume
1.5KDividend Yield
1.00%Expense Ratio
0.47%AUM
$4.9MShares Outstanding
156.4KSector Breakdown
| Sector | Weight % |
|---|---|
| Healthcare | 100.00% |
Country Allocation
| Country | Weight % |
|---|---|
| United States | 68.92% |
| Canada | 5.72% |
| Ireland | 4.54% |
| United Kingdom | 3.40% |
| Netherlands | 3.37% |
| Sweden | 2.85% |
| South Korea | 2.50% |
| Denmark | 2.14% |
| China | 1.79% |
| Japan | 1.73% |
| Australia | 1.21% |
| Switzerland | 1.05% |
| France | 0.71% |
| Other | 0.09% |
Fund Information
- Issuer
- IShares
- Category
- Healthcare
- Subcategory
- Growth
- Inception Date
- Aug 24, 2022
- Exchange
- NYSE_ARCA
- Description
- The iShares Neuroscience and Healthcare ETF seeks to track the investment results of an index composed of U.S. and non-U.S. companies that could benefit from the growth and innovation in neuroscience.
Similar ETFs
The iShares Neuroscience and Healthcare ETF (IBRN) is an exchange-traded fund issued by IShares that launched on Aug 24, 2022. It currently manages $4.9M in assets under management. The fund charges an expense ratio of 0.47%. The fund holds 57 securities in its portfolio. It falls under the Healthcare category.
Top 10 holdings represent 42.2% of the fund
| Rank | Symbol | Name | Weight % | Shares | Market Value |
|---|---|---|---|---|---|
| 1 | XENE | XENON PHARMACEUTICALS INC | 5.41% | 4,421 | $268K |
| 2 | PRAX | PRAXIS PRECISION MEDICINES INC | 5.03% | 803 | $249K |
| 3 | AXSM | AXSOME THERAPEUTICS INC | 4.48% | 1,334 | $222K |
| 4 | BIIB | BIOGEN INC | 4.17% | 1,097 | $207K |
| 5 | DNTH | DIANTHUS THERAPEUTICS INC | 4.06% | 2,313 | $201K |
| 6 | SRRK | SCHOLAR ROCK HOLDING CORP | 4.00% | 4,422 | $198K |
| 7 | SUPN | SUPERNUS PHARMACEUTICALS INC | 3.89% | 3,586 | $192K |
| 8 | ALKS | ALKERMES | 3.78% | 6,743 | $187K |
| 9 | DNLI | DENALI THERAPEUTICS INC | 3.72% | 8,594 | $184K |
| 10 | CPRX | CATALYST PHARMACEUTICALS INC | 3.65% | 7,299 | $181K |
| 11 | PTCT | PTC THERAPEUTICS INC | 3.57% | 2,576 | $177K |
| 12 | CNTA | CENTESSA PHARMACEUTICALS AMERICAN | 3.52% | 6,323 | $174K |
| 13 | NBIX | NEUROCRINE BIOSCIENCES INC | 3.36% | 1,280 | $166K |
| 14 | ARGX | ARGENX SE ADR | 3.31% | 221 | $164K |
| 15 | ACAD | ACADIA PHARMACEUTICALS INC | 3.30% | 7,254 | $164K |
Page 1 of 2
Detailed Returns
| Period | Return | ETF | Cat. Avg | vs Avg |
|---|---|---|---|---|
| 1D | -0.24% | — | ||
| 1W | +3.31% | — | ||
| 1M | +0.68% | — | ||
| 3M | +0.26% | — | ||
| 6M | +28.26% | — | ||
| YTD | +2.57% | — | ||
| 1Y | +37.85% | — | ||
| 3Y | +37.77% | — | ||
| 5Y | +32.70% | — |
Moving Averages
20-Day MA
$32.00
Above 20-Day MA50-Day MA
$32.22
Above 50-Day MA200-Day MA
$27.41
Above 200-Day MAPrice with Moving Averages
Support & Resistance
52-Week High
$33.37
Current Price
$32.84
52-Week Low
$18.44
$18.44$33.37
Current Yield
1.00%
Annual Dividend
$0.4355
Frequency
1x/year
Last Ex-Date
Dec 16, 2025
Dividend History
| Ex-Date | Amount | Pay Date |
|---|---|---|
| Dec 16, 2025 | $0.3198 | Dec 19, 2025 |
| Dec 17, 2024 | $0.1011 | Dec 20, 2024 |
| Dec 20, 2023 | $0.0063 | Dec 27, 2023 |
| Jun 7, 2023 | $0.0082 | Jun 13, 2023 |
Dividend Payments Over Time
Category Comparison
| Metric | IBRN | Healthcare(223 ETFs) | Growth(175 ETFs) |
|---|---|---|---|
| Fund Info | |||
| Expense Ratio | 0.47% | 0.60% | 0.74% |
| AUM | $4.9M | $1.25B | $868.1M |
| Dividend Yield | 1.00% | 2.75% | 11.43% |
| Avg Volume | 1.5K | 769.9K | 214.6K |
| Holdings | 57 | 182 | 63 |
| Performance | |||
| 1-Month Return | -0.08% | -3.02% | -2.47% |
| 6-Month Return | +26.19% | +5.85% | -1.44% |
| YTD Return | +0.87% | +0.17% | -2.17% |
| 1-Year Return | +37.61% | +16.65% | +18.88% |
Compare with Another ETF
Search for an ETF to compare with IBRN: